Candela Release: Studies Highlight a Revolutionary New Method of Treating Post-Operative Bruising

WAYLAND, Mass.--(BUSINESS WIRE)--Candela Corporation (NASDAQ: CLZR) announced today that two studies have reported superior results on patients who benefited from the Candela Vbeam® laser treatments for bruising resulting from cosmetic procedures. The studies concluded that the Vbeam pulsed-dye laser significantly expedited the healing process, improved outcomes, and provided greater overall patient satisfaction.

MORE ON THIS TOPIC